ReposiTrak Earnings Call Transcripts
Fiscal Year 2026
-
Q3 fiscal 2026 saw stable revenue, margin expansion, and strong cash flow, with over 98% recurring SaaS revenue. Strategic advances included new patents, a SPAR Group partnership for in-store remediation, and continued capital returns to shareholders.
-
Recurring SaaS revenue now exceeds 98% of total, with strong margin expansion and cash growth. Q2 revenue rose 7% and EPS grew 13% year-over-year, while investments in AI and traceability patents strengthen the business ahead of regulatory deadlines.
-
Revenue grew 10% year-over-year to $6M, with operating income up 28% and net income up 13%. Strong cash generation, no debt, and ongoing capital returns support a multi-year software modernization and continued growth in traceability and compliance solutions.
Fiscal Year 2025
-
Revenue and profitability grew double digits year-over-year, driven by automation, AI onboarding, and cross-selling across all business lines. Strong cash generation enabled significant shareholder returns, with no debt and a focus on recurring dividends and buybacks.
-
Q3 revenue grew 16% to $5.9M and net income rose 27% to $2M, with strong cash generation and margin expansion. Traceability, compliance, and supply chain segments all contributed to growth, and cross-selling momentum is increasing.
-
Revenue and net income grew 7% and 14% year-over-year, respectively, with strong cash flow and a 70% increase in deferred revenue. Double-digit growth is expected in the second half, driven by traceability and core business expansion.
-
Revenue grew 8% year-over-year to $5.4M, with recurring revenue at 98% and net income up 21%. Traceability now drives 6% of revenue, expected to reach 50% in three years as major retailers mandate end-to-end traceability, fueling rapid onboarding and strong cash generation.
Fiscal Year 2024
-
Fiscal 2024 saw record recurring revenue, net income, and cash, with strong growth in traceability solutions and a robust capital return to shareholders. Traceability is set to accelerate further as regulatory and market demand intensifies, supporting continued profitability and dividend growth.